According to a report by Brazilian media outlet Acessa on June 1st, British American Tobacco (BAT) is planning to build a new electronic cigarette factory in Brazil, while attempting to persuade the country's National Health Surveillance Agency (Anvisa) to change its regulatory stance on such products. Recently, the Vice President of Philip Morris International (PMI) also stated that the company would build factories if Brazil were to lift its ban on electronic cigarettes and heated tobacco products, subject to regulatory approval.
The E-Cigarette Black Market has Grown Tremendously
The Brazilian National Health Surveillance Agency has been reviewing a proposed e-cigarette bill for four years. Until a final decision is made, the Brazilian government will continue to prohibit the sale of e-cigarettes and heated non-burning tobacco products. However, companies such as BAT believe that e-cigarettes are less harmful to humans compared to traditional cigarettes.
Meanwhile, a study conducted by research institution Ipec shows that the number of electronic cigarette users in Brazil has increased from 500,000 to 2.2 million, with 4% of the population in the capital, Brasilia, now using e-cigarettes.
A study by the Industry Federation of Minas Gerais State (FIEMG) in Brazil has revealed that the electronic cigarette black market in Brazil generates an annual turnover of BRL 7.5 billion (approximately RMB 10.5 billion), with the majority of products sourced from China and Paraguay.
Due to the inability to tax illegal products, the Brazilian government loses approximately 2.2 billion reals (equivalent to 3.1 billion yuan) annually, resulting in the loss of 110,000 job opportunities in the country.
BAT and PMI Plans to Enter the Brazilian market
BAT has its largest factory in Latin America located in Minas Gerais state. The company has announced plans to expand the facility in order to accommodate the production of electronic cigarettes, initially using imported components for assembly.
Lauro Anhezini Jr, the head of science and regulatory affairs for BAT Brazil, has stated that...
British American Tobacco (BAT) cannot understand why electronic cigarettes are banned in the country when more harmful tobacco products are legally sold. Over 80 countries have already regulated electronic cigarettes. Compared to traditional cigarettes, they have a 95% reduced risk.
Previously, Gregoire Verdeaux, the Vice President of Philip Morris International (PMI), also stated that if the Brazilian National Health Surveillance Agency lifts the ban on e-cigarettes and heated tobacco products, PMI will plan on building a new factory in Rio Grande do Sul (a southern Brazilian city).
According to Weiduo, PMI is interested in investing in Brazil because it is the largest tobacco exporting country in the world. However, PMI will not add factories in the country until e-cigarettes are legalized.
It is worth noting that in March 2023, PMI held discussions with the Brazilian National Health Surveillance Agency regarding obtaining a license for the production and sale of their heated tobacco product, IQOS, in Brazil.
It is reported that PMI currently has a factory located in South Santa Cruz with 1800 employees responsible for producing tobacco products, including cigarette brands such as Marlboro, L&M, and Chesterfield.
Reference:
The electronic cigarette industry is already worth R$7.5 billion in Brazil, but the major players in the industry are not involved.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
